Purple Innovation Reports Third Quarter 2022 Results
Purple Innovation, Inc. (NASDAQ: PRPL) reported a third quarter net revenue of $143.3 million, down 16.1% year-over-year but stable compared to the previous quarter. Direct-to-Consumer (DTC) sales saw a significant decline of 25%, while wholesale revenue increased by 1.3%. Gross margin improved to 41.5%, up from 35.8% in the previous year. Operating income turned positive at $1.3 million, contrasting with losses in the past two quarters. The company raised its full-year Adjusted EBITDA outlook to $2-$7 million due to improved profitability, albeit cautious for Q4 due to high advertising costs.
- Gross margin increased by 570 basis points to 41.5% year-over-year.
- Operating income improved to $1.3 million from a loss of $(6.6) million year-over-year.
- Adjusted EBITDA raised outlook to $2 million - $7 million from a prior range of $(15) million - $(5) million.
- Net revenue decreased by 16.1% year-over-year, primarily due to declining DTC sales.
- Direct-to-Consumer revenue fell 25.0% compared to 3Q21.
- Increased advertising costs in Q4 are expected to negatively impact gross margins.
LEHI, Utah, Nov. 9, 2022 /PRNewswire/ -- Purple Innovation, Inc. (NASDAQ: PRPL) ("Purple"), a comfort innovation company known for creating the "World's First No Pressure ™ Mattress," today announced results for the third quarter ended September 30, 2022.
Third Quarter Financial Summary (Comparisons versus Third Quarter 2021 and Second Quarter 2022)1
- Net revenue was
$143.3 million , a decrease of16.1% compared to 3Q21 and relatively flat compared to 2Q22. - Wholesale revenue increased
1.3% compared to 3Q21 and decreased6.1% compared to 2Q22. - Direct-to-Consumer (DTC) revenue decreased
25.0% compared to 3Q21 while advertising spend decreased56.8% compared to 3Q21. - Gross margin increased 570 basis points year-over-year to
41.5% from35.8% in 3Q21 and increased 760 basis points compared with33.9% in 2Q22. - Operating expenses as a percent of net revenue were
40.6% compared to39.6% in 3Q21 and42.3% in 2Q22. - Operating income inclusive of
$3.4 million in one-time expenses related to the Intellibed acquisition was$1.3 million compared to an operating loss of$(6.6) million in 3Q21 and$(12.1) million in 2Q22. - Net income was
$2.3 million as compared to$2.2 million in 3Q21 and a net loss of$(8.3) million in 2Q22. - Adjusted net income was
$2.8 million , or$0.03 per diluted share as compared to adjusted net loss of$(4.9) million , or$(0.07) per diluted share in 3Q21 and adjusted net loss of$(8.8) million or$(0.11) per diluted share in 2Q22. - EBITDA was
$5.9 million compared to$2.4 million in 3Q21 and$(8.0) million in 2Q22. - Adjusted EBITDA was
$12.1 million compared to$0.6 million in 3Q21 and$(0.3) million in 2Q22. - Cash and cash equivalents, including restricted cash, were
$59.1 million at September 30, 2022.
"I am pleased with the significant improvement in profitability we delivered on both a year-over-year and quarter-over-quarter basis in a very difficult environment," said Chief Executive Officer Rob DeMartini. "Execution of our manufacturing and supply chain efficiency initiatives, along with earlier actions to right size headcount and align marketing spend with the current demand environment fueled a meaningful increase in our third quarter Adjusted EBITDA. While industry conditions remain challenging due to high inflation and a shift in consumer spending away from home related categories, we are optimistic that the work we are doing around product innovation and channel development will translate into sustainable market share gains. This includes our recent acquisition of Intellibed which elevated and strengthened our product offering and provides us with an immediate entrée into the high-margin, luxury mattress category. We are making tangible progress positioning Purple as a leading sleep and wellness brand and setting the Company up for long-term success."
Third Quarter 2022 Review
Third quarter 2022 net revenue decreased
Gross margin for the third quarter 2022 increased to
Operating expenses declined
Operating income was
Net income was
Adjusted net income which excludes adjustments for certain non-cash items and other items the Company does not consider in the evaluation of ongoing operational performance, including gains associated with the change in fair value of warrant liabilities and acquisition adjustments, was
EBITDA for the third quarter 2022 was
Balance Sheet
As of September 30, 2022, the Company had cash and cash equivalents, including restricted cash, of
Inventories at September 30, 2022 were
2022 Outlook
The Company is reiterating its previous outlook for 2022 full year revenue in the range of
The Company is raising its 2022 full year Adjusted EBITDA outlook and now expects Adjusted EBITDA to range from
Conference Call and Webcast Information
Purple Innovation, Inc. will host a live conference call to discuss financial results on November 9, 2022 at 4:30 p.m. Eastern Time. To access the call dial (888) 394-8218 (domestic) or (646) 828-8193 (international) and provide the Conference ID: 6449123. The call is also being webcast and can be accessed on the investor relations section of the Company's website, investors.purple.com. After the conference call, a webcast replay will remain available on the investor relations section of the Company's website for 30 days.
About Purple
Purple is a digitally-native vertical brand with a mission to help people feel and live better through innovative comfort solutions. We design and manufacture a variety of innovative, premium, branded comfort products, including mattresses, pillows, cushions, frames, sheets and more. Our products are the result of over 30 years of innovation and investment in proprietary and patented comfort technologies and the development of our own manufacturing processes. Our proprietary gel technology, Hyper-Elastic Polymer®, underpins many of our comfort products and provides a range of benefits that differentiate our offerings from other competitors' products. We market and sell our products through our direct-to-consumer online channels, traditional retail partners, third-party online retailers and our owned retail showrooms. For more information on Purple, visit purple.com.
Forward Looking Statements
Certain statements made in this release that are not historical facts are "forward looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking statements include but are not limited to statements relating to our expected continuing expansion of market share from investment in capacity, innovation and showrooms; our ability to achieve profitability; expected improvements in performance quarter-over-quarter; expected improvement in margin rates; our ability to successfully execute on improvement strategies; expected improvements in our operating performance; our ability to improve brand recognition; demand for our products; expectations regarding consumer behavior; our ability to develop and expand our distribution channels; our ability to accelerate product innovation and develop a path to premium products; the adequacy of our cash other capital resources; the impact of the Intellibed acquisition on our operating results and ability to enter new categories; the impact of expected advertising expense rates and discounting for Black Friday and Cyber Monday promotions; and expected financial and operating results for the full year 2022, including net revenue and Adjusted EBITDA. Statements based on historical data are not intended and should not be understood to indicate the Company's expectations regarding future events. Forward-looking statements provide current expectations or forecasts of future events or determinations. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the Company's control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Factors that could influence the realization of forward-looking statements include, among others: changes in economic, financial and end-market conditions in the markets in which we operate; fluctuations in raw material prices and cost of labor; the financial condition of our customers and suppliers; competitive pressures, including the need for technology improvement, successful new product development and introduction; changes in consumer demand, including pullbacks in consumer spending; uncertainties regarding the extent and duration of the impact of the COVID-19 pandemic on many aspects of our business, operations and financial performance; disruptions to our manufacturing processes; and the risk factors outlined in the "Risk Factors" section of our Annual Report on Form 10-K filed with the Securities and Exchange Commission (the "SEC") on March 1, 2022, as amended by our Annual Report on Form 10-K/A filed with the SEC on March 16, 2022 and our Quarterly Reports on Form 10-Q filed with the SEC. The Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Non-GAAP Financial Measures
EBITDA, adjusted EBITDA, adjusted net income, and adjusted net income per diluted share are non-GAAP financial measures that remove the impact of certain non-cash and non-recurring costs. Management believes that the use of such non-GAAP financial measures provides investors with additional useful information with respect to the impact of various adjustments, which we view as a better measure of our operating performance. Refer to the attached table for the reconciliation of such non-GAAP financial measures to the most comparable GAAP financial measure.
With respect to the Company's Adjusted EBITDA outlook for full year 2022, a quantitative reconciliation to the corresponding GAAP information cannot be provided without unreasonable effort because of the inherent difficulty of accurately forecasting the occurrence and financial impact of the various adjusting items necessary for such reconciliation that have not yet occurred, are out of our control, or cannot be reasonably predicted, including but not limited to warrant liabilities and stock based compensation. For the same reasons, the Company is unable to assess the probable significance of the unavailable information, which could have a material impact on its future GAAP financial results.
Investor Contact:
Brendon Frey, ICR
brendon.frey@icrinc.com
203-682-8200
1 Reconciliations for non-GAAP financial measures to the most directly comparable GAAP financial measures are included in the "RECONCILIATION OF GAAP TO NON-GAAP MEASURES" tables at the end of this press release.
PURPLE INNOVATION, INC. | ||||||||
September 30, | December 31, | |||||||
Assets | ||||||||
Current assets: | ||||||||
Cash, cash equivalents and restricted cash | $ | 59,143 | $ | 91,616 | ||||
Accounts receivable, net | 30,022 | 25,430 | ||||||
Inventories, net | 91,393 | 98,690 | ||||||
Prepaid expenses | 8,806 | 8,064 | ||||||
Other current assets | 5,349 | 5,702 | ||||||
Total current assets | 194,713 | 229,502 | ||||||
Property and equipment, net | 137,418 | 112,614 | ||||||
Operating lease right-of-use assets | 101,615 | 68,037 | ||||||
Goodwill | 6,441 | — | ||||||
Intangible assets, net | 24,069 | 13,204 | ||||||
Deferred income taxes | 220,771 | 217,791 | ||||||
Other long-term assets | 1,665 | 1,322 | ||||||
Total assets | $ | 686,692 | $ | 642,470 | ||||
Liabilities and Stockholders' Equity | ||||||||
Current liabilities: | ||||||||
Accounts payable | $ | 53,138 | $ | 79,752 | ||||
Accrued sales returns | 5,300 | 7,116 | ||||||
Accrued compensation | 11,138 | 8,928 | ||||||
Customer prepayments | 3,786 | 10,854 | ||||||
Accrued sales tax | 2,298 | 4,672 | ||||||
Accrued rebates and allowances | 8,051 | 10,169 | ||||||
Operating lease obligations – current portion | 12,641 | 7,053 | ||||||
Warrant liabilities | 122 | — | ||||||
Other current liabilities | 12,072 | 13,470 | ||||||
Total current liabilities | 108,546 | 142,014 | ||||||
Debt, net of current portion | 36,451 | 94,113 | ||||||
Operating lease obligations, net of current portion | 114,436 | 81,159 | ||||||
Warrant liabilities | — | 4,343 | ||||||
Tax receivable agreement liability, net of current portion | 161,970 | 162,239 | ||||||
Other long-term liabilities, net of current portion | 16,986 | 12,061 | ||||||
Total liabilities | 438,389 | 495,929 | ||||||
Commitments and contingencies (Note 13) | ||||||||
Stockholders' equity: | ||||||||
Class A common stock; | 9 | 7 | ||||||
Class B common stock; | — | — | ||||||
Additional paid-in capital | 528,972 | 407,591 | ||||||
Accumulated deficit | (281,389) | (261,825) | ||||||
Total stockholders' equity | 247,592 | 145,773 | ||||||
Noncontrolling interest | 711 | 768 | ||||||
Total stockholders' equity | 248,303 | 146,541 | ||||||
Total liabilities and stockholders' equity | $ | 686,692 | $ | 642,470 |
PURPLE INNOVATION, INC. | ||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||
Revenues, net | $ | 143,280 | $ | 170,781 | $ | 430,568 | $ | 539,796 | ||||||||
Cost of revenues | 83,867 | 109,701 | 270,717 | 309,505 | ||||||||||||
Gross profit | 59,413 | 61,080 | 159,851 | 230,291 | ||||||||||||
Operating expenses: | ||||||||||||||||
Marketing and sales | 37,007 | 48,841 | 127,339 | 163,053 | ||||||||||||
General and administrative | 19,166 | 17,037 | 55,833 | 54,024 | ||||||||||||
Research and development | 1,927 | 1,784 | 5,818 | 5,430 | ||||||||||||
Total operating expenses | 58,100 | 67,662 | 188,990 | 222,507 | ||||||||||||
Operating income (loss) | 1,313 | (6,582) | (29,139) | 7,784 | ||||||||||||
Other income (expense): | ||||||||||||||||
Interest income (expense), net | (717) | 10 | (2,447) | (1,129) | ||||||||||||
Other income (expense), net | 1,107 | 12 | 988 | (30) | ||||||||||||
Change in fair value – warrant liabilities | (53) | 5,362 | 4,221 | 19,369 | ||||||||||||
Tax receivable agreement income | — | 846 | — | 639 | ||||||||||||
Total other income (expense), net | 337 | 6,230 | 2,762 | 18,849 | ||||||||||||
Net income (loss) before income taxes | 1,650 | (352) | (26,377) | 26,633 | ||||||||||||
Income tax benefit (expense) | 631 | 2,479 | 6,617 | (1,005) | ||||||||||||
Net income (loss) | 2,281 | 2,127 | (19,760) | 25,628 | ||||||||||||
Net income (loss) attributable to noncontrolling interest | 3 | (44) | (196) | 55 | ||||||||||||
Net income (loss) attributable to Purple Innovation, Inc. | $ | 2,278 | $ | 2,171 | $ | (19,564) | $ | 25,573 | ||||||||
Net income (loss) per share: | ||||||||||||||||
Basic | $ | 0.03 | $ | 0.03 | $ | (0.25) | $ | 0.39 | ||||||||
Diluted | $ | 0.03 | $ | (0.05) | $ | (0.25) | $ | 0.09 | ||||||||
Weighted average common shares outstanding: | ||||||||||||||||
Basic | 85,666 | 66,335 | 78,544 | 65,741 | ||||||||||||
Diluted | 86,115 | 67,287 | 78,992 | 68,319 |
PURPLE INNOVATION, INC. | ||||||||||||||||
Three Months Ended | Nine Months Ended September 30, | |||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||
Cash flows from operating activities: | ||||||||||||||||
Net income (loss) | $ | 2,281 | $ | 2,127 | $ | (19,760) | $ | 25,628 | ||||||||
Adjustments to reconcile net income (loss) to net cash provided in operating activities: | ||||||||||||||||
Depreciation and amortization | 4,622 | 2,811 | 12,205 | 6,355 | ||||||||||||
Non-cash interest | 523 | 131 | 883 | 388 | ||||||||||||
Change in fair value - warrant liabilities | 53 | (5,362) | (4,221) | (19,369) | ||||||||||||
Tax receivable agreement expense | — | (846) | — | (639) | ||||||||||||
Stock-based compensation | 795 | 765 | 2,612 | 2,357 | ||||||||||||
Gain from effective settlement of preexisting relationship | (1,421) | — | (1,421) | — | ||||||||||||
Deferred income taxes | (689) | (4,907) | (6,850) | (1,737) | ||||||||||||
Changes in operating assets and liabilities: | ||||||||||||||||
Accounts receivable | 6,607 | (2,466) | 459 | 1,541 | ||||||||||||
Inventories | (2,325) | (19,250) | 11,479 | (18,319) | ||||||||||||
Prepaid inventory and other assets | (3,589) | 4,432 | (108) | 2,169 | ||||||||||||
Operating lease, net | 2,227 | 752 | 6,405 | 1,537 | ||||||||||||
Accounts payable | 10,412 | 9,584 | (26,615) | (2,199) | ||||||||||||
Accrued sales returns | 189 | (59) | (1,816) | (1,525) | ||||||||||||
Accrued compensation | 1,236 | 4,185 | 1,590 | (817) | ||||||||||||
Customer prepayments | (1,400) | (8,051) | (7,122) | 3,030 | ||||||||||||
Accrued rebates and allowances | 736 | 1,201 | (2,118) | (2,820) | ||||||||||||
Other accrued liabilities | 2,073 | 3,616 | 3,924 | 4,552 | ||||||||||||
Net cash provided by (used in) operating activities | 22,330 | (11,337) | (30,474) | 132 | ||||||||||||
Cash flows from investing activities: | ||||||||||||||||
Cash, cash equivalents and restricted cash acquired from acquisition, net of cash paid | 3,648 | — | 3,648 | — | ||||||||||||
Purchase of property and equipment | (7,189) | (13,984) | (31,422) | (40,146) | ||||||||||||
Investment in intangible assets | (815) | (1,067) | (2,637) | (1,352) | ||||||||||||
Net cash used in investing activities | (4,356) | (15,051) | (30,411) | (41,498) | ||||||||||||
Cash flows from financing activities: | ||||||||||||||||
Payments on term loan | — | (563) | (2,531) | (1,688) | ||||||||||||
Payments on revolving line of credit | — | — | (55,000) | — | ||||||||||||
Payments for debt issuance costs | — | — | (1,242) | — | ||||||||||||
Proceeds from stock offering | — | — | 93,125 | — | ||||||||||||
Payments for public offering costs | — | — | (259) | — | ||||||||||||
Proceeds from InnoHold indemnification payment | — | — | — | 4,142 | ||||||||||||
Tax receivable agreement payments | — | — | (5,847) | (628) | ||||||||||||
Distributions to members | — | (104) | — | (957) | ||||||||||||
Proceeds from exercise of warrants | — | — | — | 116 | ||||||||||||
Proceeds from exercise of stock options | — | 590 | 166 | 1,042 | ||||||||||||
Net cash provided by (used in) financing activities | — | (77) | 28,412 | 2,027 | ||||||||||||
Net increase (decrease) in cash | 17,974 | 26,465 | (32,473) | (39,339) | ||||||||||||
Cash, beginning of the period | 41,169 | 110,081 | 91,616 | 122,955 | ||||||||||||
Cash, cash equivalents and restricted cash, end of the period | $ | 59,143 | $ | 83,616 | $ | 59,143 | $ | 83,616 | ||||||||
Supplemental disclosures of cash flow information: | ||||||||||||||||
Cash paid during the period for interest | $ | 487 | $ | (469) | $ | 1,832 | $ | 389 | ||||||||
Cash paid during the period for income taxes | $ | — | $ | 61 | $ | 219 | $ | 4,495 | ||||||||
Supplemental schedule of non-cash investing and financing activities: | ||||||||||||||||
Property and equipment included in accounts payable | $ | 3,643 | $ | 2,340 | $ | 3,463 | $ | 5,707 | ||||||||
Issuance of common stock for Intellibed acquisition | $ | 26,106 | $ | — | $ | 26,106 | $ | — | ||||||||
Non-cash leasehold improvements | $ | — | $ | — | $ | — | $ | 3,238 | ||||||||
Accrued distributions | $ | — | $ | 304 | $ | 228 | $ | 304 | ||||||||
Tax receivable agreement liability | $ | — | $ | (4) | $ | — | $ | 776 | ||||||||
Deferred income taxes | $ | — | $ | (5) | $ | — | $ | 969 | ||||||||
Exercise of liability warrants | $ | — | $ | 149 | $ | — | $ | 64,321 |
PURPLE INNOVATION, INC.
RECONCILIATION OF GAAP TO NON-GAAP MEASURES
(In thousands)
Management believes that the use of the following non-GAAP financial measures provides investors with additional useful information with respect to the impact of various adjustments, which we view as a better measure of our operating performance. These non-GAAP financial measures are EBITDA, adjusted EBITDA, adjusted net income, and adjusted net income per diluted share. Other companies may calculate these non-GAAP measures differently than we do. These non-GAAP measures have limitations as analytical tools, and you should not consider them in isolation or as a substitute for our financial results prepared in accordance with GAAP.
Reconciliation of GAAP Net Income (Loss) to Non-GAAP EBITDA and Adjusted EBITDA
A reconciliation of GAAP net income (loss) to the non-GAAP measures of EBITDA and adjusted EBITDA is provided below. EBITDA represents net income (loss) income before interest expense, other (income) expense, net, and depreciation and amortization. Adjusted EBITDA represents EBITDA excluding costs incurred due to stock-based compensation expense, debt extinguishment, warrant liability, vendor separation fee, nonrecurring legal fees, acquisition expenses, interim CFO and consulting fees and severance costs. We believe EBITDA and Adjusted EBITDA provide additional useful information with respect to the impact of various adjustments and provide meaningful measures of our operating performance.
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||
GAAP net income (loss) | $ | 2,281 | 2,127 | (19,760) | 25,628 | |||||||||||
Interest expense | 717 | (10) | 2,447 | 1,129 | ||||||||||||
Income tax (benefit) expense | (631) | (2,479) | (6,617) | 1,005 | ||||||||||||
Other income, net | (1,107) | (12) | (988) | 30 | ||||||||||||
Depreciation and amortization | 4,622 | 2,811 | 12,205 | 6,355 | ||||||||||||
EBITDA | 5,882 | 2,437 | (12,713) | 34,147 | ||||||||||||
Adjustments: | ||||||||||||||||
Warrant Liability | 53 | (5,362) | (4,221) | (19,369) | ||||||||||||
Stock-based compensation expense | 795 | 765 | 2,612 | 2,357 | ||||||||||||
Vendor separation fee | — | — | 3,136 | — | ||||||||||||
Tax Receivable Agreement income | — | (846) | — | (639) | ||||||||||||
Legal fees | 227 | 222 | 493 | 9,881 | ||||||||||||
Acquisition expenses | 3,389 | — | 3,389 | — | ||||||||||||
Executive interim and search costs | 1,014 | 1,021 | 4,084 | 2,166 | ||||||||||||
Severance costs | — | 278 | 2,469 | 593 | ||||||||||||
Showroom opening costs | 740 | 692 | 2,316 | 1,182 | ||||||||||||
New production facility start-up costs | — | 290 | 348 | 2,856 | ||||||||||||
Previous period sales tax liability | — | 964 | — | 1,049 | ||||||||||||
COVID-19 related expenses | — | 102 | 331 | 141 | ||||||||||||
Adjusted EBITDA | $ | 12,100 | $ | 563 | $ | 2,244 | $ | 34,364 |
Reconciliation of GAAP Net Income to non-GAAP Adjusted Net Income and Adjusted Net Income per Diluted Share
Our presentation of adjusted net income assumes that all net income is attributable to Purple Innovation, Inc. (i.e. there is no allocation of net income or loss to noncontrolling interests), which assumes the full exchange at the beginning of the period of all outstanding Paired Securities for shares of Class A common stock of Purple Innovation, Inc., adjusted for certain nonrecurring items that we do not believe directly reflect our core operations. Adjusted net income per share, diluted, is calculated by dividing adjusted net income by the total shares of Class A common stock outstanding plus any dilutive warrants, options and restricted stock as calculated in accordance with GAAP and assuming the full exchange of all outstanding Paired Securities as of the beginning of each period presented. Adjusted net income and adjusted net income per diluted share, are supplemental measures of operating performance that do not represent, and should not be considered, alternatives to net income and earnings per share, as calculated in accordance with GAAP. We believe adjusted net income and adjusted net income per diluted share, supplement GAAP measures and enable us to more effectively evaluate our performance period-over-period. A reconciliation of net income (loss), the most directly comparable GAAP measure, to adjusted net income and the computation of adjusted net income per diluted share, are set forth below:
(in thousands, except per share amounts) | Three Months Ended | Nine Months Ended | ||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||
Net income (loss) | $ | 2,281 | $ | 2,127 | $ | (19,760) | $ | 25,628 | ||||||||
Income tax (benefit) expense, as reported | (631) | (2,479) | (6,617) | 1,005 | ||||||||||||
Tax receivable agreement income | — | (846) | — | (639) | ||||||||||||
Change in fair value – warrant liabilities | 53 | (5,362) | (4,221) | (19,369) | ||||||||||||
Secondary offering expenses | — | — | — | 7,858 | ||||||||||||
Acquisition expenses | 3,389 | — | 3,389 | — | ||||||||||||
Gain on effective settlement in acquisition | (1,421) | — | (1,421) | — | ||||||||||||
Adjusted net income (loss) before income taxes | 3,671 | (6,560) | (28,630) | 14,483 | ||||||||||||
Adjusted income tax benefit (expense)(1) | (870) | 1,666 | 6,785 | (3,679) | ||||||||||||
Adjusted net income (loss) | $ | 2,801 | $ | (4,894) | $ | (21,845) | $ | 10,804 | ||||||||
Adjusted net income (loss) per share, diluted | $ | 0.03 | $ | (0.07) | $ | (0.28) | $ | 0.16 | ||||||||
Adjusted weighted-average shares outstanding, diluted(2) | 86,115 | 67,287 | 78,992 | 68,775 |
(1) | Represents the estimated effective tax rate of |
(2) | Assumes dilutive warrants, options and restricted stock calculated in accordance with GAAP and the full exchange of all outstanding Paired Securities for shares of Class A common stock as of the beginning of the period. |
A reconciliation of net income (loss) per share, diluted, to adjusted net income per diluted share is set forth below for the three and six months ended June 30, 2021 and 2020: |
For the Three Months Ended | ||||||||||||||||||||||||
September 30, 2022 | September 30, 2021 | |||||||||||||||||||||||
Net Income | Weighted | Net | Net Income | Weighted | Net Income per | |||||||||||||||||||
Net income (loss) attributable to Purple Innovation Inc.(1) | $ | 2,278 | 86,115 | $ | 0.03 | $ | 2,171 | 67,287 | $ | (0.05) | ||||||||||||||
Assumed exchange of shares(2) | 3 | — | (44) | — | ||||||||||||||||||||
Net income (loss) | 2,281 | 2,127 | ||||||||||||||||||||||
Adjustments to arrive at adjusted income (loss) before taxes(3) | 1,390 | (8,687) | ||||||||||||||||||||||
Adjusted income (loss) before taxes | 3,671 | (6,560) | ||||||||||||||||||||||
Adjusted income tax benefit(4) | (870) | 1,666 | ||||||||||||||||||||||
Adjusted net income (loss) | $ | 2,801 | 86,115 | $ | 0.03 | $ | (4,894) | 67,287 | $ | (0.07) |
(1) | Represents net income attributable to Purple Innovation, Inc. and the associated weighted average diluted shares, of Class A common stock outstanding. |
(2) | Assumes the full exchange of all outstanding Paired Securities for shares of Class A common stock as of the beginning of the period. Also assumes the addition of net income(loss) attributable to noncontrolling interests corresponding with the assumed exchange of the Paired Securities for shares of Class A common stock. |
(3) | Represents the total impact of all adjustments identified in the adjusted net income table above to arrive at adjusted income before income taxes. Also assumes the dilutive warrants, options and restricted stock as calculated in accordance with GAAP. |
(4) | Represents the estimated effective tax rate of |
For the Nine Months Ended | ||||||||||||||||||||||||
September 30, 2022 | September 30, 2021 | |||||||||||||||||||||||
Net Income | Weighted | Net | Net Income | Weighted | Net Income per | |||||||||||||||||||
Net income (loss) attributable to Purple Innovation Inc.(1) | $ | (19,564) | 78,992 | $ | (0.25) | $ | 25,573 | 68,319 | $ | 0.09 | ||||||||||||||
Assumed exchange of shares(2) | (196) | — | 55 | 456 | ||||||||||||||||||||
Net income (loss) | (19,760) | 25,628 | ||||||||||||||||||||||
Adjustments to arrive at adjusted income before taxes(3) | (8,870) | (11,145) | ||||||||||||||||||||||
Adjusted income before taxes | (28,630) | 14,483 | ||||||||||||||||||||||
Adjusted income tax benefit (expense)(4) | 6,785 | (3,679) | ||||||||||||||||||||||
Adjusted net income | $ | (21,845) | 78,992 | $ | (0.28) | $ | 10,804 | 68,775 | $ | 0.16 |
(1) | Represents net income attributable to Purple Innovation, Inc. and the associated weighted average diluted shares, of Class A common stock outstanding. |
(2) | Assumes the full exchange of all outstanding Paired Securities for shares of Class A common stock as of the beginning of the period. Also assumes the addition of net income attributable to noncontrolling interests corresponding with the assumed exchange of the Paired Securities for shares of Class A common stock. |
(3) | Represents the total impact of all adjustments identified in the adjusted net income table above to arrive at adjusted income before income taxes. Also assumes the dilutive warrants, options and restricted stock as calculated in accordance with GAAP. |
(4) | Represents the estimated effective tax rate of |
View original content to download multimedia:https://www.prnewswire.com/news-releases/purple-innovation-reports-third-quarter-2022-results-301673510.html
SOURCE Purple Innovation, Inc.
FAQ
What were the net revenues for Purple Innovation (PRPL) in Q3 2022?
How did Purple Innovation's adjusted EBITDA change in Q3 2022?
What is the outlook for Purple Innovation's revenue in 2022?
What were the changes in Purple Innovation's direct-to-consumer revenue?